Have questions about your scans, treatments, or what comes next?
Wondering about DOTATATE scans, PRRT, or radiation safety? Curious about clinical trials, what options are available now, and what is on the horizon? Not sure what comes after PRRT, or what treatments may be considered if your tumor does not express somatostatin receptors? We will answer practical questions that matter in your day-to-day life.
Join us in Los Angeles on Sunday, May 31, for a dynamic patient education event, a collaboration between NorCal Carcinet and the Neuroendocrine Cancer Foundation, and in partnership with the Society of Nuclear Medicine and Molecular Imaging (SNMMI), a leading medical and scientific organization dedicated to advancing nuclear medicine and molecular imaging.
Each year, Josh Mailman, President of NorCal CarciNET, organizes this event alongside the SNMMI Annual Conference. With this yearās conference taking place at the Los Angeles Convention Center, we are honored to collaborate on this meaningful program. The event will be hybrid and completely free, with options to attend in person or via livestream. For those attending in person, parking, lunch, and a networking reception are all provided at no cost.
Speakers
Richard Baum, MD, Curanosticum Wiesbaden, Germany
Lisa Bodei, MD, PhD, Memorial Sloan Kettering Cancer Center, NY
Gabriel Fine, MD, City of Hope Cancer Center, Duarte, CA
George Fisher, MD, PhD, Stanford Cancer Center, Palo Alto, CA
Eric Liu, MD, Healing NET Foundation, Denver, CO
Erik Mittra, MD, PhD, Oregon Health & Science University, Portland, OR
Why attend in person?
Get your questions answered by leading neuroendocrine cancer experts
Learn about the latest advances in imaging, treatment, and clinical trials
Connect with other patients, caregivers, and professionals who understand the journey
Explore the exhibit hall and hear directly from scientists as they break down their research in a patient-friendly way
This is more than just an educational event. It is an opportunity to feel more informed, more confident, and more empowered to actively engage in your care.
Agenda
9:30 - 9:50 am
Guided Exhibit Hall Tour (in person only) - South Exhibit Hall
Pick up badges at the SNMMI Hub, located at the front of the South Exhibit Hall at 9:15 a.m.
10:00 - 11:45 am
General Session - Room 152
10:00 - 10:10 am - Welcome and Announcements
10:10-11:00 am - What is Nuclear Medicine and Molecular Imaging? / Radiation Safety
Martin Tornai, PhD, National Institute of Biomedical Imaging and Bioengineering National Institutes of Health
11:00 - 11:45 am - How to Understand and Evaluate Clinical Trials
George Fisher, MD, PhD, Stanford Cancer Center, Palo Alto, CA
11:45 am - 1:00 pm
Lunch - Complimentary Buffet (in person only) - Room 152
12:15 - 12:45 pm - Seeing is Believing: Innovations in Imaging to Improve Patient Care (in person only)
Simon Cherry, PhD, The Cherry Laboratory, University of California Davis
1:00 - 4:30 pm
NETS - Exploring the Latest Innovations in Diagnosis and Treatment - Room 152
1:15 - 1:20 pm - Patient Story
1:20 - 1:40 pm - Neuroendocrine Tumor Overview
George Fisher, MD, PhD, Stanford University
1:40 - 2:00 pm- "Meet the Author" Poster Presentations
Lisa Bodei, MD, PhD, Sloan Kettering Cancer Center, New York, NY
Frank Lin, MD, National Institute of Cancer
2:00 - 2:20 pm - Optimizing Your Health for your NET Journey
Eric Liu, MD, Healing NET Foundation
2:20 -Ā 2:40 pm - Break
2:40 - 3:00 pm- The Role of Interventional Radiology
Gabriel Fine, MD, City of Hope Cancer Center, Duarte, CA
3:00 - 3:10 pm - Overview of Theranostics in the USA and Europe
Lisa Bodei, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY
3:10 - 3:30 pm - Theranostics and Clinical Trials: Where We are Now in the USA
Erik Mittra, MD, PhD, Oregon Health & Science University
3:30 - 3:50 pm - The Expanding Role of Theranostics in G3 NET and BeyondĀ
Richard Baum, MD, PhD, Curanosticum Wiesbaden, Germany
3:50 - 4:30 pm - Q&A
4:30 - 5:30 pm - Reception (in person only) - Room 153-C
Enjoy complimentary hors d'oeuvres and drinks
Ā